◆ 会议时间：2025年10月12-16日
◆ 会议地点：韩国 首尔

◆ 会议简介：

2025年第27届世界神经病学大会(WCN 2025)将于2025年10月12-15日在韩国首尔举行，本次会议由世界神经病学联合会(WFN)与韩国神经学协会(KNA)联合组织，预计有来自世界各地的4000余名专业人士与会（2019年阿联酋迪拜会议有来自128个国家的4000余名代表参会）。

世界神经病学联盟(WFN)于1957年在布鲁塞尔成立，是一个代表着全球120多个国家与地区神经学学会的国家神经病学会联盟。世界神经病学联合会(WFN)的使命宣是通过提供高质量的教育与培训，在全世界范围内促进神经病学的发展，改善全人类大脑健康。WFN每两年举行一次世界大会（世界神经病会大会WCN），在世界各地（非洲，美洲，亚洲，欧洲）轮流举行（未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网-lingyuint.com）。

WCN 2025 - XXVII World Congress of Neurology - World Federation of Neurology (WFN)

Date:
October 12-15, 2025

Venue:
COEX Convention & Exhibition Center
Seoul, Korea

Organized by:
World Federation of Neurology (WFN)
Korean Neurological Association (KNA)

摘要征文投稿：

点此提交摘要>>>Submit Abstract>>>

RULES FOR SUBMISSION

Please read the submission rules before submitting an abstract.

• Abstracts must be submitted online via the website only.
  ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Presentation Type: Abstracts may be submitted for oral or poster or ePoster (Virtual attendance) presentation.
  The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• Limitations:
• The same person may submit up to 4 abstracts regardless of the presenting author.
• The same person may serve as presenting author on up to 4 abstracts.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by the Early Registration Deadline will be scheduled for presentation and included for publication.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Congress publications.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• Previously Presented/Published Policy:
  – Abstracts may be submitted that were presented at another Congress
• Abstracts must be submitted in English.
• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.
• Instructions for preparation of presentations will be made available on the congress website.
• Embargo Policy:

WCN has no embargo policy – all abstracts will be available to view via the Congress website at the time of acceptance

​GUIDELINES FOR SUBMISSION

​Before you begin, please prepare the following information:

• ​Presenting author’s contact details:
  – Full first and family name(s)
  – Email address
  – Affiliation details: department, institution / hospital, city, state (if relevant), country
  – Phone number
• Author and co-authors’ details
• Preferred Presentation type: Oral, Poster or E-Poster ​
• Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.
• Abstract text – limited to 250 words including acknowledgements. Please note: word count is affected when tables are included.
• Abstract topic– select the abstract topic per the list of topics.
• Images– The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format.
• Abstracts should clearly state:
  Background and aims
  Methods
  Results
  Conclusions 
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers or other identifying information.
• The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline if not submitted, drafts will be deleted.
• Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
• You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us on wcn_abstracts@kenes.com  if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.

ABSTRACT SUBMITTERS’ DECLARATION

During abstract submission you will be asked to confirm that you agree to the following:

1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submissionand I am aware that it will be published as submitted.
2. Submission of the abstract constitutes the consent of all authorsto publication (e.g. Congress website, programmes, other promotions, etc.)
3. The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to WCN25 and Kenes International Organizers of Congresses SA and its affiliates (together: the “Organizers“), nor the publication of any such Content by each of the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
4. The Abstract Submitter grants each of the Organizers the license and right to use, reproduce, publish, translate, distribute, and display the Content or any part thereof, in any manner and on any platform or media whatsoever, in each Organizer’s absolute discretion, on a royalty-free, perpetual, irrevocable nonexclusive basis.
5. I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
6. I understand that the presenting author must be a registered participant.
7. The Organizers reserve the right to remove from publication and/or presentation an abstract which does not comply with the above.
8. I understand that I must select a specific Theme, Topic and/or Sub-Topic for my abstract allocation. Although the Committee will work hard to honour this selection, this cannot be guaranteed.  The Committee reserves the right to change the Theme, Topic or Sub-Topic under which the abstract was originally submitted.
9. I confirm to have received the consent of all authors for the processing of their contact details by Kenes and the Organizers.